225 related articles for article (PubMed ID: 10191208)
1. The role of interleukin (IL)-2 and IL-4 in herpes simplex virus type 1 ocular replication and eye disease.
Ghiasi H; Cai S; Slanina SM; Perng GC; Nesburn AB; Wechsler SL
J Infect Dis; 1999 May; 179(5):1086-93. PubMed ID: 10191208
[TBL] [Abstract][Full Text] [Related]
2. Enhanced clearance of herpes simplex virus type 1 and reduced herpetic eye disease in STAT6 knockout mice is associated with increased IL-2.
Ghiasi H; Osorio Y; Nesburn AB; Wechsler SL
Virology; 2002 Oct; 302(2):286-93. PubMed ID: 12441072
[TBL] [Abstract][Full Text] [Related]
3. Protection against herpes simplex virus-induced eye disease after vaccination with seven individually expressed herpes simplex virus 1 glycoproteins.
Ghiasi H; Bahri S; Nesburn AB; Wechsler SL
Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1352-60. PubMed ID: 7775113
[TBL] [Abstract][Full Text] [Related]
4. Recombinant herpes simplex virus type 1 (HSV-1) codelivering interleukin-12p35 as a molecular adjuvant enhances the protective immune response against ocular HSV-1 challenge.
Osorio Y; Ghiasi H
J Virol; 2005 Mar; 79(6):3297-308. PubMed ID: 15731224
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic periocular vaccination with a subunit vaccine induces higher levels of herpes simplex virus-specific tear secretory immunoglobulin A than systemic vaccination and provides protection against recurrent spontaneous ocular shedding of virus in latently infected rabbits.
Nesburn AB; Burke RL; Ghiasi H; Slanina SM; Wechsler SL
Virology; 1998 Dec; 252(1):200-9. PubMed ID: 9875329
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-10 treatment can suppress stromal keratitis induced by herpes simplex virus type 1.
Tumpey TM; Elner VM; Chen SH; Oakes JE; Lausch RN
J Immunol; 1994 Sep; 153(5):2258-65. PubMed ID: 8051423
[TBL] [Abstract][Full Text] [Related]
7. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
Morrison LA; Knipe DM
Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
[TBL] [Abstract][Full Text] [Related]
8. Nonneutralizing antibody against the glycoprotein K of herpes simplex virus type-1 exacerbates herpes simplex virus type-1-induced corneal scarring in various virus-mouse strain combinations.
Ghiasi H; Cai S; Slanina S; Nesburn AB; Wechsler SL
Invest Ophthalmol Vis Sci; 1997 May; 38(6):1213-21. PubMed ID: 9152241
[TBL] [Abstract][Full Text] [Related]
9. Preventive effect of local plasmid DNA vaccine encoding gD or gD-IL-2 on herpetic keratitis.
Inoue T; Inoue Y; Nakamura T; Yoshida A; Takahashi K; Inoue Y; Shimomura Y; Tano Y; Fujisawa Y; Aono A; Hayashi K
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4209-15. PubMed ID: 11095617
[TBL] [Abstract][Full Text] [Related]
10. Involvement of CD8+ T-cells in exacerbation of corneal scarring in mice.
Osorio Y; Cai S; Hofman FM; Brown DJ; Ghiasi H
Curr Eye Res; 2004; 29(2-3):145-51. PubMed ID: 15512961
[TBL] [Abstract][Full Text] [Related]
11. The role of neutralizing antibody and T-helper subtypes in protection and pathogenesis of vaccinated mice following ocular HSV-1 challenge.
Ghiasi H; Wechsler SL; Cai S; Nesburn AB; Hofman FM
Immunology; 1998 Nov; 95(3):352-9. PubMed ID: 9824497
[TBL] [Abstract][Full Text] [Related]
12. Antibody-dependent enhancement of HSV-1 infection by anti-gK sera.
Ghiasi H; Perng GC; Nesburn AB; Wechsler SL
Virus Res; 2000 Jul; 68(2):137-44. PubMed ID: 10958985
[TBL] [Abstract][Full Text] [Related]
13. An M2 Rather than a T
Lee DH; Ghiasi H
J Virol; 2018 May; 92(10):. PubMed ID: 29491152
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of interleukin-2 by a recombinant herpes simplex virus type 1 attenuates pathogenicity and enhances antiviral immunity.
Ghiasi H; Osorio Y; Perng GC; Nesburn AB; Wechsler SL
J Virol; 2002 Sep; 76(18):9069-78. PubMed ID: 12186890
[TBL] [Abstract][Full Text] [Related]
15. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.
Bettahi I; Nesburn AB; Yoon S; Zhang X; Mohebbi A; Sue V; Vanderberg A; Wechsler SL; BenMohamed L
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4643-53. PubMed ID: 17898288
[TBL] [Abstract][Full Text] [Related]
16. Induction of humoral and cellular immunity against latent HSV-1 infections by DNA immunization in BALB/c mice.
Ghaemi A; Soleimanjahi H; Bamdad T; Soudi S; Arefeian E; Hashemi SM; Ebtekar M
Comp Immunol Microbiol Infect Dis; 2007 Jul; 30(4):197-210. PubMed ID: 17335902
[TBL] [Abstract][Full Text] [Related]
17. Involvement of STAT4 in IgG subtype switching and ocular HSV-1 replication in mice.
Allen SJ; Mott KR; Ghiasi H
Mol Vis; 2010 Jan; 16():98-104. PubMed ID: 20104254
[TBL] [Abstract][Full Text] [Related]
18. Comparison of adjuvant efficacy of herpes simplex virus type 1 recombinant viruses expressing TH1 and TH2 cytokine genes.
Osorio Y; Ghiasi H
J Virol; 2003 May; 77(10):5774-83. PubMed ID: 12719570
[TBL] [Abstract][Full Text] [Related]
19. CD8+-dependent CNS demyelination following ocular infection of mice with a recombinant HSV-1 expressing murine IL-2.
Osorio Y; La Point SF; Nusinowitz S; Hofman FM; Ghiasi H
Exp Neurol; 2005 May; 193(1):1-18. PubMed ID: 15817260
[TBL] [Abstract][Full Text] [Related]
20. Recombinant herpes simplex virus type 1 expressing murine interleukin-4 is less virulent than wild-type virus in mice.
Ghiasi H; Osorio Y; Perng GC; Nesburn AB; Wechsler SL
J Virol; 2001 Oct; 75(19):9029-36. PubMed ID: 11533166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
